skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Comparing adult child and spousal caregiver burden and potential causes
Comparing adult child and spousal caregiver burden and potential causes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparing adult child and spousal caregiver burden and potential causes

Fenton, Anny ; Keating, Nancy Lynn ; Ornstein, Katherine A. ; Kent, Erin E. ; Litzelman, Kristin ; Rowland, Julia H. ; Wright, Alexi A.

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.12127-12127 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
12
The effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitor (ICI) efficacy in patients with metastatic urothelial carcinoma (mUC) in real-world setting
The effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitor (ICI) efficacy in patients with metastatic urothelial carcinoma (mUC) in real-world setting
Material Type:
Artigo 		Adicionar ao Meu Espaço

The effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitor (ICI) efficacy in patients with metastatic urothelial carcinoma (mUC) in real-world setting

Gupta, Shilpa ; Khan, Mohammad Siddique ; Radakovich, Nathan ; Wei, Wei ; Ornstein, Moshe Chaim ; Gilligan, Timothy D. ; Mian, Omar Y. ; Dawsey, Scott

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.417-417 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
13
Safety and efficacy outcomes in immune checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts) requiring treatment interruption (TI) due to immune-related adverse events (irAEs)
Safety and efficacy outcomes in immune checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts) requiring treatment interruption (TI) due to immune-related adverse events (irAEs)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy outcomes in immune checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts) requiring treatment interruption (TI) due to immune-related adverse events (irAEs)

Nizam, Amanda ; Sheng, Iris Yeong- Fung ; Allman, Kimberly D. ; Martin, Allison ; Gilligan, Timothy D. ; Gupta, Shilpa ; Ornstein, Moshe Chaim

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.411-411 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
14
Impact of primary tumor location, histology, and host factors on objective response to immune checkpoint inhibitors in metastatic urothelial carcinoma
Impact of primary tumor location, histology, and host factors on objective response to immune checkpoint inhibitors in metastatic urothelial carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of primary tumor location, histology, and host factors on objective response to immune checkpoint inhibitors in metastatic urothelial carcinoma

Dawsey, Scott ; Khan, Mohammad Siddique ; Radakovich, Nathan ; Wei, Wei ; Mian, Omar Y. ; Ornstein, Moshe Chaim ; Gilligan, Timothy D. ; Gupta, Shilpa

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.493-493 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
15
Assessing treatment preferences among patients with advanced/metastatic renal cell carcinoma in the United States: A discrete choice experiment
Assessing treatment preferences among patients with advanced/metastatic renal cell carcinoma in the United States: A discrete choice experiment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessing treatment preferences among patients with advanced/metastatic renal cell carcinoma in the United States: A discrete choice experiment

Ornstein, Moshe Chaim ; Rosenblatt, Lisa ; Ejzykowicz, Flavia ; Guttenplan, Sarah ; Del Tejo, Viviana ; Yin, Xin ; Beusterien, Kathleen M. ; Mackie, deMauri S ; Will, Oliver ; Skiles, Grace ; DeCongelio, Marc ; Senglaub, Steven S.

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.630-630 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
16
Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC)
Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC)

Chen, Yu-Wei ; Beckermann, Katy ; Haake, Scott Mattox ; Reddy, Anupama ; Shyr, Yu ; Atkins, Michael B. ; Mar, Nataliya ; Ornstein, Moshe Chaim ; Pal, Sumanta Monty ; Zhang, Tian ; Rathmell, Wendy Kimryn ; Rini, Brian I.

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS742-TPS742 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
17
Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial
Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial

Runcie, Karie ; Ornstein, Moshe Chaim ; Saraiya, Biren ; Krishnamurthi, Venkatesh ; Lee, Byron H ; Anderson, Christopher B. ; DeCastro, Guarionex Joel ; McKiernan, James M. ; Dallos, Matthew ; Mayer, Tina M. ; Marron, Melanie ; Kulik, Alexandria ; Singer, Eric A. ; Stein, Mark N.

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.691-691 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
18
Phase II trial of intermittent therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with front-line ipilimumab and nivolumab (Ipi/Nivo)
Phase II trial of intermittent therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with front-line ipilimumab and nivolumab (Ipi/Nivo)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II trial of intermittent therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with front-line ipilimumab and nivolumab (Ipi/Nivo)

George, Laeth ; Wei, Wei ; Diaz-Montero, C. Marcela ; Martin, Allison ; Vyas, Neil ; Basu, Arnab ; Beckermann, Katy ; Nizam, Amanda ; Wee, Christopher Eing ; Gilligan, Timothy D. ; Gupta, Shilpa ; Rini, Brian I. ; Ornstein, Moshe Chaim

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.672-672 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
19
A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC)
A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC)

Shah, Neil J. ; Campbell, Matthew T ; Mao, Shifeng S. ; Ornstein, Moshe Chaim ; Haas, Naomi B. ; Gao, Xin ; Hammers, Hans J. ; Keshava-Prasad, Holavanahalli ; Yan, Hongxia ; Esquibel, Vanessa ; Geller, Robert B. ; Beckermann, Katy

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.666-666 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
20
Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC)
Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC)

Stahlfeld, Charlotte ; Emamekhoo, Hamid ; Kaufmann, Katherine ; Grivas, Petros ; Ornstein, Moshe Chaim ; Sheng, Iris Yeong- Fung ; Burkey, Caroline ; Sperger, Jamie ; Bade, Rory M. ; Schehr, Jennifer L. ; Taylor, Amy K ; Shi, Yue ; Zhao, Shuang ; Lang, Joshua Michael

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.547-547 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.